NCT03888950View on ClinicalTrials.gov

Interim FDG PET-CT in Melanoma Metastatic Patient's Treated by Anti-PD1 Therapy

NARecruitingINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

November 24, 2020

Primary Completion Date

November 24, 2022

Study Completion Date

November 30, 2027

Conditions

Metastatic Melanoma

Interventions

DIAGNOSTIC_TEST

FDG PET-CT

FDG PET/CT for oncological imaging of adult patients

Trial Locations (1)

06003

RECRUITING

CHU de Nice, Nice

All Listed Sponsors

lead

Centre Hospitalier Universitaire de Nice

OTHER